NME
GSK icon

Notis-McConarty Edward’s GSK GSK Stock Holding History

Notis-McConarty Edward’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-31,336
Closed -$1.8M – 116
2014
Q3 		$1.8M Buy
31,336
+1,600
+5% +$98.1K 1.27% 30
2014
Q2 		$1.99M Buy
29,736
+1,520
+5% +$103K 1.32% 27
2014
Q1 		$1.89M Buy
28,216
+5,420
+24% +$366K 1.31% 28
2013
Q4 		$1.52M Buy
+22,796
New +$1.48M 1.07% 32

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Notis-McConarty Edward's GSK Position: Q4 2014 in Review

Notis-McConarty Edward sold out of GSK (GSK) in Q4 2014, closing a stake of 31,336 shares — an estimated $1.8M sold.

Notis-McConarty Edward first reported a position in GSK in Q4 2013 and held it in 4 quarters. The position peaked at $1.99M in Q2 2014. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Notis-McConarty Edward reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • Notis-McConarty Edward sold 31,336 GSK shares in Q4 2014, an estimated $1.8M.
  • Notis-McConarty Edward first reported a position in GSK in Q4 2013 and held it in 4 quarters.
  • Notis-McConarty Edward's GSK position peaked at $1.99M in Q2 2014.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Notis-McConarty Edward's 13F filing for Q4 2014, filed 13 Feb 2015.